文献速递其他结缔组织病

凝血酶生成试验作为改善抗磷脂综合征疾病严重程度分层的有用工具

Thrombin generation test as a useful tool for improving disease severity stratification in antiphospholipid syndrome.
PubMed 文献 · RMD Open · 2025-07-01

本研究为单中心横断面研究,纳入114例接受维生素K拮抗剂(VKA)治疗的原发性血栓性抗磷脂综合征(APS)患者及28例非APS的VKA抗凝对照,采用校准自动血栓图检测凝血酶生成试验(TGT)。结果显示APS患者较对照的延迟时间(LT)和达峰时间(TTP)延长,且有复发史、灾难性APS(CAPS)、全部aPL阳性及Bb片段升高与LT和TTP延长强相关。作者认为TGT可能有助于在不暂停VKA的情况下改善APS疾病严重程度分层。

要点

  • 接受VKA治疗的APS患者较抗凝对照的TGT延迟时间(LT)和达峰时间(TTP)显著延长。
  • 有复发史或灾难性APS(CAPS)的患者LT和TTP延长幅度最大。
  • 全部aPL阳性及Bb片段升高与LT和TTP延长强相关。

核心结论

  • 作者认为,接受VKA治疗的APS患者较抗凝对照的TGT时间显著延长,有复发史或CAPS者延长最明显;TGT可能有助于在不暂停VKA的情况下改善APS疾病严重程度分层。

研究设计与样本

  • 单中心横断面研究,纳入符合APS分类标准、接受VKA治疗、未经选择的原发性血栓性APS患者114例(无系统性红斑狼疮)。
  • 同期纳入在本院随访的28例接受VKA的非APS患者作为对照。
  • TGT采用校准自动血栓图在核心实验室对血浆样本进行检测。

主要发现

  • 2020年1月至2023年3月共纳入114例血栓性APS患者,女性71例(62.3%),平均年龄50±14岁,距末次APS事件的中位时间为51个月(IQR 23-129个月)。
  • APS患者较抗凝对照的延迟时间(LT)和达峰时间(TTP)延长。
  • 复发史、灾难性APS(CAPS)、全部aPL阳性及Bb片段升高与LT和TTP延长强相关。

关键数值与推荐

  • APS患者中狼疮抗凝物阳性率约70%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with antiphospholipid syndrome (APS) display a wide range of clinical manifestations with similar immunological profile with the presence of lupus anticoagulant in around 70% of them. Although antiphospholipid antibodies (aPL) profile influences the risk of thrombosis in APS, APS risk stratification remains to be improved. OBJECTIVES: Our study aimed to evaluate thrombin generation test (TGT) interest to improve disease severity stratification in APS patients. PATIENTS/METHODS: In this monocentric, transversal study, we included unselected primary thrombotic APS patients, fulfilling APS classification criteria and treated by vitamin K antagonist (VKA). 28 non-APS patients under VKA followed in our hospital were included as controls. TGT was performed on plasma samples with the calibrated automated thrombogram in our core laboratory. RESULTS: Between January 2020 and March 2023, 114 thrombotic APS patients (without systemic lupus erythematosus) were included (female 71 (62.3%), mean age 50±14 years old, median duration since the last APS event of 51 months (IQR 23-129 months)). APS patients had prolonged lag time (LT) and time to peak (TTP) compared with anticoagulated controls. History of relapse, catastrophic APS (CAPS), all aPL positivities and elevated Bb fragments were strongly associated with a prolonged LT and TTP. CONCLUSIONS: Our findings suggest that APS patients under VKA had significantly prolonged TGT times compared with anticoagulated controls, with the greatest prolongations in patients with history of relapse or CAPS. Thus, TGT might be a useful tool to improve APS disease severity stratification without temporary cessation of VKA.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Yelnik C, Bauters A, Labreuche J, et al. Thrombin generation test as a useful tool for improving disease severity stratification in antiphospholipid syndrome. RMD Open. 2025. PMID: 40592722. doi:10.1136/rmdopen-2025-005489

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。